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Abstract
Background: It is unclear how often patients with pneumonia are assessed for Legionella in endemic areas.
Additionally, the sensitivity of the IDSA/ATS criteria for recommended Legionella testing is undefined.
Methods: We performed a single-center, retrospective study of patients diagnosed with Legionella pneumonia at
our hospital to determine: 1) how often Legionella diagnostic testing is obtained on patients with pneumonia at
the time of hospitalization or when pneumonia developed during hospitalization; and 2) how often patient’s with
Legionella pneumonia met at least one of the five criteria in the IDSA/ATS guidelines recommending a work-up for
Legionella. Patients with Legionella pneumonia were identified using an infection control software program. Medical
records of these patients were then reviewed.
Results: Thirty-five percent of patients with a discharge diagnosis of pneumonia had Legionella urine antigen
testing and/or a Legionella culture performed. Forty-four percent of patients who had a bronchoscopic specimen
sent for microbiologic testing had a Legionella culture performed on the bronchoscopic specimen and/or Legionella
urine antigen testing. Of 37 adult patients with Legionella pneumonia, 22 (59%) met the IDSA-ATS criteria
recommending Legionella testing.
Conclusion: Following current recommendations for Legionella testing missed 41% of Legionella cases in adults in
our single-center study. A work-up for Legionella (i.e., urine antigen test and/or culture) was performed in less than
half of patients who have a bronchoscopic specimen sent for microbiologic testing.
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Background
In the Infectious Diseases Society of America (IDSA)
and American Thoracic Society (ATS) community-
acquired pneumonia guidelines [1], Legionella pneumo-
phila urine antigen testing is recommended for patients
with any of the following: severe pneumonia requiring
intensive care unit (ICU) admission, failure of outpatient
antibiotics, active alcohol abuse, history of travel within
the previous two weeks, or pleural effusion. For every
patient with community-acquired pneumonia, empiric
treatment of Legionella is recommended using a macro-
lide or respiratory fluoroquinolone [1]. However, making
a diagnosis of Legionella allows the practitioner to more
accurately define the choice and duration of
antimicrobial therapy and such testing assists public
health officials in detecting Legionella outbreaks in com-
munity and healthcare settings.
The aims of this study were to determine: 1) how
often Legionella diagnostic testing is obtained by physi-
cians managing all patients with pneumonia; 2) how
often Legionella testing is obtained for patients who
have an heightened acuity of illness prompting broncho-
scopic evaluation as a diagnostic test for possible pneu-
monia; and 3) the sensitivity of current IDSA/ATS
guidelines for recommending Legionella testing in
patients with pneumonia.
Methods
The TII ECLYPSIS software program (Chicago, IL),
which identifies specific ICD-9 codes and billing data,
was used to retrospectively determine the number of
patients with a primary or secondary diagnosis of
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who had a bronchoscopy and a bronchoscopic specimen
sent for microbiologic testing between October 1, 2007
and March 31, 2009. The same software program was
used to identify the number of patients who had urine
Legionella antigen testing (BinaxNow, Inverness Medical
Professional Diagnostics, Princeton, NJ) or who had a
Legionella culture using standard microbiological meth-
ods [2].
The TheraDoc
® software program (Hospira, Lake For-
est, IL) was used by the Department of Epidemiology
and Infection Control at Rhode Island Hospital to pro-
spectively identify patients at least 18 years of age with
community or hospital-acquired Legionella pneumonia
between January 1, 2005 and December 31, 2009 in our
719 bed tertiary care, university-affiliated hospital in
Southern New England. For the purposes of this study,
we retrospectively assessed this data and performed
chart reviews as noted below. Each patient was included
only once; incarcerated patients were excluded due to
IRB restrictions.
Chart reviews were retrospectively performed by one
of the authors (BH) to determine demographic, labora-
tory, and clinical features of each Legionella case,
including the five criteria for Legionella testing noted in
the IDSA/ATS guideline as follows: history of alcohol
abuse, recent travel within 2 weeks, pleural effusion
upon admission, admission to an intensive care unit for
pneumonia, and failure of outpatient antibiotics. Both
electronic and paper charts were reviewed in a systema-
tic fashion. Hyponatremia was defined as sodium < 130
mEq/L. This study was approved by the Rhode Island
Hospital IRB committee (IRB Registration # 00000396).
All authors had full access to all the data in the study
and take responsibility for the integrity of the data and
accuracy of the data analysis.
Results
T h e r ew e r e3 , 9 8 2p a t i e n t so fa n ya g ew i t hap r i m a r yo r
secondary diagnosis of pneumonia between October 1,
2007 and March 31, 2009. Of these, 1,406 patients (35%)
had a Legionella urine antigen test and/or Legionella cul-
ture as follows: 1251 had a urine antigen test alone; 49
had a Legionella culture alone; and 106 had both a Legio-
nella culture and urine antigen test. During the same
time period, 626 patients underwent bronchoscopy and
had bronchoscopic specimens sent to the microbiology
laboratory for culture, 277 (44%) of whom had Legionella
testing done as follows: 122 had a Legionella culture
alone; 31 had a urine antigen test alone; and 124 had
both a Legionella culture and urine antigen test.
Forty-one adult patients with Legionella pneumonia
were identified between January 1, 2005 and December
31, 2009, 37 of which were included in the study (Table
1). Reasons for exclusion were as follows: under 18
years of age (2 cases); incarcerated patient (1 case); and
Legionella pneumonia was diagnosed and treated at an
outside hospital but the Legionella urine antigen test
remained positive when retested at admission to our
hospital (1 case). There were 6, 5, 5, 12, and 9 Legionella
cases in 2005 through 2009, respectively. All 37 cases
were L. pneumophila serogroup 1. Thirty-six cases were
diagnosed by urine antigen testing alone; one case had a
positive urine antigen test and a positive Legionella cul-
ture from a bronchoscopic specimen. Thirty-three of the
37 cases (89%) met CDC surveillance criteria for com-
munity-acquired Legionnaires’ disease; the remaining
four cases (11%) met criteria for possible hospital-
acquired pneumonia. All 4 patients with possible hospi-
tal-acquired Legionella p n e u m o n i aw e r ei m m u n o s u p -
pressed. Twenty-two of 37 cases (59%) met at least one
of the five IDSA/ATS criteria recommending Legionella
testing as follows: 14 (38%) were admitted to an ICU; 7
(19%) had a pleural effusion on initial chest radiograph;
6 (16%) had a history of alcohol abuse; 4 (11%) failed
outpatient antibiotics prior to admission; and 1 (3%) had
a history of recent travel. Among the 37 cases, the most
common findings were: immunocompromised status, 24
cases (65%); hyponatremia, 24 cases (65%); diarrhea 14
cases (38%), and ICU admission, 14 cases (38%). Chart
review revealed that liver function testing was not per-
formed in 8 patients and presence or absence of diar-
rhea was not recorded in 2 patients.
Discussion
Thirty-five percent of patients with a discharge diagnosis
of pneumonia between October 1, 2007 and March 31,
2009 were tested for Legionella.O fp a t i e n t sw h o s e
acuity of illness led to the need for bronchoscopy and
who had a bronchoscopic specimen sent for microbiolo-
gic testing, 44% had Legionella testing by urine antigen
or culture [3]. These results suggest that available meth-
odologies to diagnose Legionella may be underutilized in
regions of the USA where Legionella is endemic.
Of 37 cases of Legionnaires’ disease diagnosed in our
hospital over 5 years, 22 (59%) met IDSA/ATS criteria
for Legionella testing. Thus, 41% of Legionella cases may
have gone undiagnosed if testing was only done accord-
ing to the IDSA/ATS recommendations. Of the 5 clini-
cal features recommended by IDSA/ATS guidelines,
admission to ICU and the presence of a pleural effusion
were most helpful in identifying patients with Legionella
pneumonia. The low number of patients presenting with
antibiotic failure may reflect the widespread use of
macrolides and quinolones by primary care providers.
Nearly all of our cases were community-acquired and all
cases were L. pneumophila serogroup 1. Thirty-six of our
37 cases were diagnosed solely by urine antigen testing.
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other serogroups may have been missed because Legio-
nella culture was underutilized. The CDC estimates 2.5 to
5.8 Legionella cases/100,000 population yearly in the USA
[4,5]. In Rhode Island, epidemiologic data on Legionnaires’
disease are available from 2004 to 2008 [6], during which
time the annual incidence ranged from 2.0 to 4.7 cases/
100,000 population. There was a trend towards an increas-
ing incidence of Legionella pneumonia in Rhode Island
during this time period similar to national data suggesting
increasing incidence of Legionnaires’ disease from 1990 to
2005, with the most pronounced rise in noted in the
Northeastern USA [7].
Limitations of our study reflect a single-center experi-
ence. As such, the incidence of Legionnaires’ disease in
our geographic location may not be representative of
other settings. Since we used coded data to determine
the number of patients with a discharge diagnosis of
pneumonia, we may have underestimated or overesti-
mated the true number of pneumonia cases at our hos-
pital. We combined community and possible hospital-
acquired cases to assess the sensitivity of the IDSA/ATS
guidelines although the guidelines specifically address
community-acquired pneumonia. However, the sensitiv-
ity of the recommended testing for Legionella in our 33
community-acquired cases was 58%. Lastly, education
programs and hospital-specific diagnostic algorithms in
other institutions may promote more widespread Legio-
nella testing.
A number of studies have searched for clinical fea-
tures that are specific for Legionnaires’ disease without
particular success [8,9]. In endemic areas such as the
Eastern USA, where pretest probability is higher [7], our
study suggests the possible need to extend urine Legio-
nella antigen testing beyond what currently occurs, as
suggested by the number of Legionella pneumonia cases
that did not meet the IDSA/ATS criteria for testing, the
proportion of pneumonia cases that are currently being
tested for Legionnaires’ disease, and the possibility of
rising incidence. The best strategy at the present time
may be to screen all cases of community-acquired pneu-
monia requiring hospital admission in endemic locales
but the cost-effectiveness of such a strategy first needs
to be assessed. Such a testing program will likely identify
more Legionella pneumonia cases, thereby focusing anti-
microbial therapy. Additionally, such testing would bet-
ter assist public health departments by improving
outbreak detection, and it may lead to a better under-
standing of the epidemiology of Legionnaires’ disease
and its prevention.
Conclusions
A diagnostic work-up for Legionella (i.e., urine antigen
testing or culture of respiratory specimens) is performed
Table 1 Characteristics of Adult Patients with Legionella Pneumonia, 2005-2009
Patients with Legionella that met IDSA/
ATS criteria for Legionella testing
Patients with Legionella that did not meet
IDSA/ATS criteria for Legionella testing
All patients with
Legionella
pneumonia
Male 15 9 24 (65%)
Recent travel 1 0 1 (3%)
History of alcohol abuse 6 0 6 (16%)
Anti-TNF therapy 1 1 2 (5%)
Daily steroid use 0 1 1 (3%)
Cancer 4 4 8 (22%)
Diabetes 5 6 11 (29%)
COPD 5 4 9 (24%)
Solid-organ transplant
recipient
0 1 1 (3%)
HIV infection 1 0 1 (3%)
Receipt of antibiotics
prior to hospitalization
4 0 4 (11%)
Pleural effusion present
at hospital admission
7 0 7 (19%)
ICU admission 14 0 14 (38%)
Abnormal liver function
tests
15 5 20 (54%)
Hyponatremia (Sodium <
130 mEq/L)
9 4 13 (35%)
Crude mortality 6 0 6 (16%)
SD, standard deviation; TNF, tumor necrosis factor; COPD, chronic obstructive pulmonary disease; abnormal liver function test defined as above reference range;
Crude mortality defined as in-hospital death or discharge to hospice care with impending death.
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Page 3 of 4in less than half of patients with pneumonia in our
endemic region. If Legionella testing was curtailed to
those recommended in the IDSA/ATS community-
acquired pneumonia guidelines, the diagnosis of Legio-
nella pneumonia would have been missed in 41% of our
cases. Thus, Legionella pneumonia may be underdiag-
nosed and more widespread Legionella testing should be
considered to better delineate the choice and duration
of antimicrobial therapy and to assist in uncovering
clusters of Legionella in the community or healthcare
setting.
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